300006 萊美藥業
按盤價 
6.520 +1.090 (+20.074%)
6.520 +1.090 (+20.074%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -7.419 | -4.439 | -0.425 | -3.210 | -6.042 |
| 總資產報酬率 ROA (%) | -4.961 | -3.056 | -0.300 | -2.297 | -3.310 |
| 投入資產回報率 ROIC (%) | -5.902 | -3.623 | -0.360 | -2.799 | -4.112 | 邊際利潤分析 |
| 銷售毛利率 (%) | 55.768 | 64.388 | 69.330 | 73.498 | 71.466 |
| 營業利潤率 (%) | -18.844 | -13.301 | 6.278 | -10.857 | -5.725 |
| 息稅前利潤/營業總收入 (%) | -20.209 | -11.865 | -2.123 | -7.963 | -7.057 |
| 淨利潤/營業總收入 (%) | -16.312 | -10.066 | -1.119 | -8.624 | -8.646 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 52.885 | 115.869 | -2,145.438 | 151.840 | 119.260 |
| 價值變動淨收益/利潤總額(%) | 14.402 | 24.991 | 2,421.015 | -7.682 | -45.226 |
| 營業外收支淨額/利潤總額(%) | 0.438 | -40.090 | -1,464.312 | -27.631 | 33.806 | 償債能力分析 |
| 流動比率 (X) | 2.088 | 2.208 | 2.928 | 2.489 | 2.590 |
| 速動比率 (X) | 1.867 | 1.957 | 2.624 | 2.201 | 2.353 |
| 資產負債率 (%) | 31.485 | 34.052 | 26.591 | 28.483 | 24.418 |
| 帶息債務/全部投入資本 (%) | 17.616 | 20.736 | 11.579 | 14.840 | 7.790 |
| 股東權益/帶息債務 (%) | 461.123 | 376.362 | 735.392 | 568.487 | 1,157.975 |
| 股東權益/負債合計 (%) | 216.603 | 192.839 | 270.667 | 244.128 | 301.736 |
| 利息保障倍數 (X) | 15.756 | 5.005 | 0.841 | -14.654 | -4.432 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 116.208 | 134.811 | 131.612 | 153.285 | 133.152 |
| 存貨周轉天數 (天) | 190.452 | 236.777 | 244.692 | 276.541 | 233.973 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 03/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
